1. Khalimov, Y.S., Grebenyuk, A.N., Legeza, V.I., et al., The current state and prospects for improving specialized care for acute bone marrow syndrome of radiation etiology, Voen.-Med. Zh., 2013, vol. 334, no. 1, pp. 25–32.
2. Weers, J.G. and Miller, D.P., Formulation design of dry powders for inhalation, J. Pharm. Sci., 2015, vol. 104, no. 10, pp. 3259–3288.
3. Vasin, M.V., Classification of radioprotective agents as a reflection of the current state and prospects for the development of radiation pharmacology, Radiats. Biol. Radioekol., 2013, vol. 53, no. 5, pp. 459–467.
4. Grebenyuk, A.N., Zatsepin, V.V., Nazarov, V.B., and Vlasenko, T.N., Modern opportunities of drug prevention and early therapy of radiation injuries, Voen.-Med. Zh., 2011, vol. 332, no. 2, pp. 13–17.
5. Grebenyuk, A.N. and Legeza, V.I., Prospects for the use of radioprotectors to improve the effectiveness of medical antiradiation protection of the Armed Forces, Voen.-Med. Zh., 2013, vol. 334, no. 7, pp. 46–50.